Literature DB >> 25701033

A fibrin-supported myocardial organ culture for isolation of cardiac stem cells via the recapitulation of cardiac homeostasis.

Jong-Tae Kim1, Hye Jin Chung2, Ji-Yeon Seo1, Young-Il Yang3, Min-Young Choi1, Hyeong-In Kim1, Tae-Hyun Yang4, Won-Jin Lee1, Young Chul Youn1, Hye Jung Kim1, Yeon Mee Kim1, Hyukjin Lee2, Yang-Soo Jang5, Seung-Jin Lee6.   

Abstract

There is great interest in the development of cardiac stem cells (CSCs) cell-based therapeutics; thus, clinical translation requires an efficient method for attaining therapeutic quantities of these cells. Furthermore, an in vitro model to investigate the mechanisms regulating the cardiac homeostasis is crucial. We sought to develop a simple myocardial culture method for enabling both the recapitulation of myocardial homeostasis and the simultaneous isolation of CSCs. The intact myocardial fragments were encapsulated 3-dimensionally into the fibrin and cultured under dynamic conditions. The fibrin provided secure physical support and substratum to the myocardium, which mediated integrin-mediated cell signaling that allowed in situ renewal, outgrowth and cardiomyogenic differentiation of CSCs, mimicking myocardial homeostasis. Since our culture maintained the myocardial CSCs niches, it was possible to define the identity of in vitro renewed CSCs that situated in the interstitium between cardiomyocytes and microvessels. Lastly, the use of matrix-restricted fibrinolysis enabled the selective isolation of outgrown CSCs that retained the clonogenicity, long-term growth competency and cardiovascular commitment potential. Collectively, this myocardial culture might be used as an alternative tool for studying cardiac biology and developing cell-based therapeutics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac homeostasis; Cardiac stem cells; Fibrin; Myocardial infarction; Organ culture; Stem cell niche

Mesh:

Substances:

Year:  2015        PMID: 25701033     DOI: 10.1016/j.biomaterials.2015.01.041

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  4 in total

Review 1.  How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction.

Authors:  Zachary Lister; Katey J Rayner; Erik J Suuronen
Journal:  Front Bioeng Biotechnol       Date:  2016-07-18

Review 2.  Biodegradable Nanopolymers in Cardiac Tissue Engineering: From Concept Towards Nanomedicine.

Authors:  Saeed Mohammadi Nasr; Navid Rabiee; Sakineh Hajebi; Sepideh Ahmadi; Yousef Fatahi; Masoumehossadat Hosseini; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Mohammad Rabiee; Vahid Jajarmi; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2020-06-18

3.  Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells.

Authors:  In Sook Kang; Joowon Suh; Mi-Ni Lee; Chaeyoung Lee; Jing Jin; Changjin Lee; Young Il Yang; Yangsoo Jang; Goo Taeg Oh
Journal:  BMB Rep       Date:  2020-02       Impact factor: 4.778

4.  Tanshinone‑IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes.

Authors:  Yeqing Fang; Chengcheng Duan; Shaoyuan Chen; Zhenguo Liu; Bimei Jiang; Wen Ai; Lei Wang; Peiyi Xie; Hongcheng Fang
Journal:  Int J Mol Med       Date:  2021-07-02       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.